Forest Laboratories and Gedeon Richter Plc announced preliminary results from a Phase 3 trial of cariprazine (RGH-188) in patients with acute mania associated with bipolar I disorder.
Treatment with the antidepressants fluoxetine hydrochloride and venlafaxine hydrochloride is associated with a reduction in suicidal thoughts and behavior in adult and geriatric patients and has no impact on such thoughts or behavior in youths.
A multi-assay, serum-based test can be used to distinguish individuals with major depressive disorder (MDD) from controls, with high specificity and sensitivity.
Many adolescents who are treated in emergency departments for deliberately harming themselves do not receive adequate mental health assessments or follow-up community care.
Use of antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs), during pregnancy increases the risk of persistent pulmonary hypertension in newborns.
This patient information fact sheet provides information on the definition, causes, symptoms, treatments and self-help measures for depression.
Treatment, lifestyle, and the use of specific antidepressants may contribute to obesity among survivors of childhood cancer, according to a study published online Dec. 19 in the Journal of Clinical Oncology.
The FDA has approved the first generic versions of Lilly’s Zyprexa (olanzapine tablets) and Zyprexa Zydis (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.
The FDA announced that MedWatch has updated its information on the potential drug interaction between Zyvox (linezolid; Pfizer) and serotonergic psychiatric medications.
The FDA has approved a 60mg dosage strength tablet of fluoxetine, manufactured by Edgemont Pharmaceuticals.
